Income Statement Chemring Group PLC

Equities

CHG

GB00B45C9X44

Aerospace & Defense

Market Closed - London S.E. Other stock markets 16:35:16 20/05/2026 BST			5-day change	1st Jan Change
486.80 ^GBX	+2.53%		+5.83%	+3.03%

05-18	Tate & Lyle cut; Morgan Stanley raises Burberry	AN
05-14	Multiconsult to Provide Multidisciplinary Technical Services for Chemring Nobel Project in Norway	MT

641ec0c17438cc6f.z5uicqTH502SU_WXIm-W9YhH0YtRnzM0za7DQc-YxGg.p6n7GOCE1QDGP6TnZBfMoskeu_hh8Qt6h8byKYTTpwaN7MU666u1NPQYoA

Published financial data: CHEMRING GROUP PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: October	2021	2022	2023	2024	2025
Revenues	393M	443M	473M	510M	498M
Total Revenues	393M	443M	473M	510M	498M
Cost of Goods Sold, Total	-	-	-	167M	164M
Gross Profit	393M	443M	473M	344M	333M
Selling General & Admin Expenses, Total	100K	100K	600K	196M	203M
Stock-Based Compensation (IS)	5.3M	6.4M	4.4M	-	5.1M
R&D Expenses	-	-	-	14.2M	14.2M
Depreciation & Amortization - (IS)	-	-	-	21M	22.8M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	2.3M	2.9M
Other Operating Expenses	337M	381M	398M	48.6M	12.1M
Other Operating Expenses, Total	342M	388M	403M	282M	260M
Operating Income	51.2M	55.3M	69.7M	61.6M	72.7M
Interest Expense, Total	-1.5M	-1.4M	-700K	-4.8M	-5.7M
Net Interest Expenses	-1.5M	-1.4M	-700K	-4.8M	-5.7M
Currency Exchange Gains (Loss)	800K	-2M	-2.7M	-300K	-800K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	50.5M	51.9M	66.3M	56.5M	66.2M
Restructuring Charges	-	-	-	-	-2.5M
Merger & Related Restructuring Charges	-1.6M	-2M	-3.7M	-3.4M	-3M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-100K	1.9M	-	-1.7M	-100K
Asset Writedown	-	-	-18.5M	-	-
Legal Settlements	-	-	-	3.1M	200K
Other Unusual Items	-	-	-	-1.2M	6.9M
EBT, Incl. Unusual Items	48.8M	51.8M	44.1M	53.3M	67.7M
Income Tax Expense	7.3M	4.4M	6.4M	10.6M	14.4M
Earnings From Continuing Operations	41.5M	47.4M	37.7M	42.7M	53.3M
Earnings Of Discontinued Operations	-	-	-32.3M	-3.2M	-5.1M
Net Income to Company	41.5M	47.4M	5.4M	39.5M	48.2M
Net Income - (IS)	41.5M	47.4M	5.4M	39.5M	48.2M
Net Income to Common Incl Extra Items	41.5M	47.4M	5.4M	39.5M	48.2M
Net Income to Common Excl. Extra Items	41.5M	47.4M	37.7M	42.7M	53.3M
Per Share Items
Net EPS - Basic	0.15	0.17	0.02	0.14	0.18
Basic EPS - Continuing Operations	0.15	0.17	0.13	0.16	0.2
Basic Weighted Average Shares Outstanding	282M	281M	282M	273M	271M
Net EPS - Diluted	0.14	0.16	0.02	0.14	0.17
Diluted EPS - Continuing Operations	0.14	0.16	0.13	0.15	0.19
Diluted Weighted Average Shares Outstanding	288M	288M	289M	279M	276M
Normalized Basic EPS	0.11	0.12	0.15	0.13	0.15
Normalized Diluted EPS	0.11	0.11	0.14	0.13	0.15
Dividend Per Share	0.05	0.06	0.07	0.08	0.08
Payout Ratio	28.67	30.38	320.37	50.13	45.23
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	74.3M	76.5M	89.9M	83M	94.9M
EBITA	57.5M	60M	72.7M	63.9M	74.4M
EBIT	51.2M	55.3M	69.7M	61.6M	72.7M
EBITDAR	75.1M	77.4M	91.2M	83.8M	96.3M
Effective Tax Rate - (Ratio)	14.96	8.49	14.51	19.89	21.27
Total Current Taxes	5.3M	3.3M	9.6M	6.9M	10.7M
Total Deferred Taxes	2M	1.1M	-3.2M	3.7M	3.7M
Normalized Net Income	31.56M	32.44M	41.44M	35.31M	41.38M
Interest Capitalized	500K	600K	2.8M	1.7M	3.2M
Interest on Long-Term Debt	700K	400K	600K	700K	1.6M
Non-Cash Pension Expense	100K	100K	600K	7.5M	400K
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	64.3M	79.3M	131M	130M	105M
Net Rental Expense, Total	800K	900K	1.3M	800K	1.4M
Imputed Operating Lease Interest Expense	269K	485K	1.52M	702K	790K
Imputed Operating Lease Depreciation	531K	415K	-223K	98.48K	610K
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	5.3M	6.4M	7.8M	9M	7.3M
Total Stock-Based Compensation	5.3M	6.4M	7.8M	9M	7.3M

Fiscal Period: October	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.8M	19.8M	6.4M	45M	65.3M
Total Cash And Short Term Investments	5.8M	19.8M	6.4M	45M	65.3M
Accounts Receivable, Total	50.9M	44.7M	41.3M	46.1M	59.1M
Other Receivables	3.7M	8.5M	24.3M	36.5M	33.3M
Total Receivables	54.6M	53.2M	65.6M	82.6M	92.4M
Inventory	80.7M	99.6M	102M	127M	143M
Prepaid Expenses	5.5M	6.2M	6.9M	7M	10.3M
Other Current Assets, Total	1.5M	2.4M	3.1M	8.1M	20.6M
Total Current Assets	148M	181M	184M	270M	332M
Gross Property Plant And Equipment	285M	339M	358M	415M	486M
Accumulated Depreciation	-86.5M	-108M	-116M	-127M	-132M
Net Property Plant And Equipment	199M	231M	242M	288M	355M
Goodwill	109M	118M	100M	98.5M	99.6M
Other Intangibles, Total	14.1M	11.4M	9.6M	10M	43.7M
Deferred Tax Assets Long-Term	18.2M	32.3M	36.9M	7.3M	11.2M
Deferred Charges Long-Term	30M	34.6M	17.6M	18.6M	20.2M
Other Long-Term Assets, Total	13.7M	11.2M	5.9M	100K	1.9M
Total Assets	532M	620M	596M	692M	863M
Liabilities
Accounts Payable, Total	13.1M	14.7M	16.3M	27.9M	23.3M
Accrued Expenses, Total	22M	24.5M	21.7M	36.5M	49.1M
Short-term Borrowings	400K	-	-	43M	20.5M
Current Portion of Long-Term Debt	-	-	-	-	26.7M
Current Portion of Leases	1.4M	1.8M	1.1M	2.1M	3.1M
Current Income Taxes Payable	12M	7.9M	8.2M	8.8M	3.9M
Unearned Revenue Current, Total	21.6M	30.5M	53.2M	30.3M	42.8M
Other Current Liabilities	32M	34.3M	41.6M	73.3M	32M
Total Current Liabilities	102M	114M	142M	222M	201M
Long-Term Debt	28.2M	21M	14.2M	43.8M	91.7M
Long-Term Leases	2.4M	4.2M	5.5M	8.9M	12.4M
Unearned Revenue Non Current	-	-	-	24M	134M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	30.7M	45.2M	43.8M	17.6M	28.5M
Other Non Current Liabilities	14.9M	17.9M	12.3M	19.6M	13.5M
Total Liabilities	179M	202M	218M	336M	481M
Common Stock, Total	2.8M	2.8M	2.8M	2.7M	2.7M
Additional Paid In Capital	307M	308M	309M	309M	309M
Retained Earnings	48.6M	79.9M	58.6M	40.8M	73.2M
Treasury Stock	-	-	-	-	-
Comprehensive Income and Other	-5.7M	27.7M	8.4M	3.8M	-3.1M
Total Common Equity	353M	418M	378M	356M	382M
Total Equity	353M	418M	378M	356M	382M
Total Liabilities And Equity	532M	620M	596M	692M	863M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	283M	284M	281M	273M	273M
ECS Total Common Shares Outstanding	283M	284M	281M	273M	273M
Book Value / Share	1.25	1.47	1.35	1.31	1.4
Tangible Book Value	230M	289M	268M	248M	239M
Tangible Book Value Per Share	0.81	1.02	0.96	0.91	0.88
Total Debt	32.4M	27M	20.8M	97.8M	154M
Net Debt	26.6M	7.2M	14.4M	52.8M	89.1M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-13.7M	-11.2M	-5.9M	-100K	100K
Debt Equivalent Oper. Leases	6.4M	7.2M	10.4M	6.4M	11.2M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	36.6M	48.1M	49.6M	57.4M	61.2M
Inventories - Work In Process, Total	27.2M	38.8M	33.1M	54.7M	62.6M
Inventories - Finished Goods, Total	16.9M	12.7M	19M	15M	19.4M
Land - (BS)	131M	145M	154M	178M	156M
Machinery, Total	148M	183M	191M	222M	179M
Full Time Employees	2.26K	2.3K	2.6K	2.67K	2.7K
Accumulated Allowance for Doubtful Accounts (Supple)	300K	500K	200K	100K	-
Order Backlog	501M	651M	922M	1.04B	1.35B

Fiscal Period: October	2021	2022	2023	2024	2025
Net Income	41.5M	47.4M	5.4M	39.5M	48.2M
Depreciation & Amortization - CF	18.2M	18.1M	18.6M	21M	22.8M
Amortization of Goodwill and Intangible Assets - (CF)	6.3M	4.7M	3M	2.3M	1.7M
Depreciation & Amortization, Total	24.5M	22.8M	21.6M	23.3M	24.5M
Amortization of Deferred Charges, Total - (CF)	600K	100K	700K	1.3M	2.3M
(Gain) Loss From Sale Of Asset	100K	-1.9M	-	1.7M	200K
Asset Writedown & Restructuring Costs	-	2.2M	15.6M	-	-
Stock-Based Compensation (CF)	5.3M	6.4M	4.4M	5.8M	5.1M
Net Cash From Discontinued Operations	-400K	-	-2.7M	-3M	-3.3M
Other Operating Activities, Total	5.9M	2.4M	33.8M	17.6M	5.7M
Change In Accounts Receivable	900K	4.5M	-18.7M	-16.9M	-19.9M
Change In Inventories	7.9M	-6.4M	-18.2M	-30.1M	-23.7M
Change In Accounts Payable	-10.3M	2.9M	23.7M	41.8M	51.8M
Change in Other Net Operating Assets	-300K	100K	300K	-	200K
Cash from Operations	75.7M	80.5M	65.9M	81M	91.1M
Capital Expenditure	-28M	-31.5M	-32.7M	-64.8M	-93.4M
Sale of Property, Plant, and Equipment	-	6M	-	-	-
Cash Acquisitions	-5.1M	-	-7.2M	-	-13.5M
Divestitures	400K	-	-	-	6.6M
Sale (Purchase) of Intangible assets	-2.2M	-3M	-1.5M	-4.8M	-12.1M
Other Investing Activities, Total	-	-2M	2M	22M	23.5M
Cash from Investing	-34.9M	-30.5M	-39.4M	-47.6M	-88.9M
Long-Term Debt Issued, Total	29.2M	30M	60.1M	100M	145M
Total Debt Issued	29.2M	30M	60.1M	100M	145M
Long-Term Debt Repaid, Total	-57.3M	-43.2M	-68.6M	-72.6M	-72.8M
Total Debt Repaid	-57.3M	-43.2M	-68.6M	-72.6M	-72.8M
Issuance of Common Stock	400K	100K	600K	900K	900K
Repurchase of Common Stock	-7.1M	-7M	-14M	-41M	-6.6M
Common Dividends Paid	-11.9M	-14.4M	-17.3M	-19.8M	-21.8M
Common & Preferred Stock Dividends Paid	-11.9M	-14.4M	-17.3M	-19.8M	-21.8M
Other Financing Activities, Total	-3.7M	-1.3M	-1M	-4.8M	-4.7M
Cash from Financing	-50.4M	-35.8M	-40.2M	-37.3M	40M
Foreign Exchange Rate Adjustments	300K	200K	300K	-500K	600K
Net Change in Cash	-9.3M	14.4M	-13.4M	-4.4M	42.8M
Supplemental Items
Cash Interest Paid	2.6M	1.3M	700K	4M	3.3M
Cash Income Tax Paid (Refund)	2.6M	8.5M	9.3M	6.5M	13.3M
Levered Free Cash Flow	33.86M	20.59M	52.22M	-12.2M	-45.32M
Unlevered Free Cash Flow	34.8M	21.46M	52.66M	-9.2M	-41.76M
Change In Net Working Capital	-2.6M	7.9M	-13.2M	11.7M	15.8M
Net Debt Issued / Repaid	-28.1M	-13.2M	-8.5M	27.4M	72.2M

Fiscal Period: October	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.97	6	7.16	5.98	5.84
Return on Total Capital	8.23	8.33	10.32	9.02	9.17
Return On Equity %	12.16	12.3	9.47	11.62	14.44
Return on Common Equity	12.16	12.3	9.47	11.62	14.44
Margin Analysis
Gross Profit Margin %	100	100	100	67.36	66.95
SG&A Margin	0.03	0.02	0.13	38.42	40.86
EBITDA Margin %	18.89	17.28	19.02	16.26	19.08
EBITA Margin %	14.62	13.55	15.38	12.52	14.95
EBIT Margin %	13.02	12.49	14.75	12.07	14.61
Income From Continuing Operations Margin %	10.55	10.7	7.98	8.37	10.71
Net Income Margin %	10.55	10.7	1.14	7.74	9.69
Net Avail. For Common Margin %	10.55	10.7	7.98	8.37	10.71
Normalized Net Income Margin	8.02	7.33	8.77	6.92	8.32
Levered Free Cash Flow Margin	8.61	4.65	11.05	-2.39	-9.11
Unlevered Free Cash Flow Margin	8.85	4.85	11.14	-1.8	-8.39
Asset Turnover
Asset Turnover	0.73	0.77	0.78	0.79	0.64
Fixed Assets Turnover	2	2.06	2	1.93	1.55
Receivables Turnover (Average Receivables)	7.4	9.26	12.67	11.68	9.46
Inventory Turnover (Average Inventory)	-	-	-	1.46	1.22
Short Term Liquidity
Current Ratio	1.44	1.59	1.29	1.22	1.65
Quick Ratio	0.59	0.64	0.51	0.58	0.78
Operating Cash Flow to Current Liabilities	0.74	0.71	0.46	0.37	0.45
Days Sales Outstanding (Average Receivables)	49.33	39.4	28.81	31.34	38.59
Days Outstanding Inventory (Average Inventory)	-	-	-	251.32	300.06
Average Days Payable Outstanding	-	-	-	42.13	51.77
Cash Conversion Cycle (Average Days)	-	-	-	240.53	286.88
Long Term Solvency
Total Debt/Equity	9.18	6.46	5.5	27.45	40.42
Total Debt / Total Capital	8.41	6.07	5.21	21.54	28.78
LT Debt/Equity	8.67	6.03	5.2	14.79	27.25
Long-Term Debt / Total Capital	7.94	5.66	4.93	11.61	19.41
Total Liabilities / Total Assets	33.62	32.58	36.54	48.52	55.74
EBIT / Interest Expense	34.13	39.5	99.57	12.83	12.75
EBITDA / Interest Expense	50.47	55.79	130.43	17.69	17.05
(EBITDA - Capex) / Interest Expense	31.8	33.29	83.71	4.19	0.67
Total Debt / EBITDA	0.43	0.35	0.23	1.15	1.59
Net Debt / EBITDA	0.35	0.09	0.16	0.62	0.92
Total Debt / (EBITDA - Capex)	0.68	0.58	0.35	4.87	40.63
Net Debt / (EBITDA - Capex)	0.56	0.15	0.25	2.63	23.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.29	12.59	17.86	8	1.88
Gross Profit, 1 Yr. Growth %	-2.29	12.59	17.86	5.65	1.37
EBITDA, 1 Yr. Growth %	0.68	2.96	25.03	-10.46	4.98
EBITA, 1 Yr. Growth %	1.05	4.35	31.23	-15.7	3.48
EBIT, 1 Yr. Growth %	6.67	8.01	35.6	-15.38	4.45
Earnings From Cont. Operations, 1 Yr. Growth %	19.6	14.22	-15.09	13.26	28.43
Net Income, 1 Yr. Growth %	19.6	14.22	-88.61	631.48	22.03
Normalized Net Income, 1 Yr. Growth %	15.83	2.77	38.12	-18.71	2.64
Diluted EPS Before Extra, 1 Yr. Growth %	20	13.89	-14.94	16.79	29.53
Accounts Receivable, 1 Yr. Growth %	-8.12	-12.18	24.02	11.62	28.2
Inventory, 1 Yr. Growth %	-11.61	23.42	2.11	24.98	12.67
Net Property, Plant and Equip., 1 Yr. Growth %	2.42	16.41	4.71	18.83	23.25
Total Assets, 1 Yr. Growth %	-1.83	16.67	-3.82	16.05	24.71
Tangible Book Value, 1 Yr. Growth %	12.47	25.48	-7	-7.68	-3.67
Common Equity, 1 Yr. Growth %	7.04	18.51	-9.47	-5.87	7.21
Cash From Operations, 1 Yr. Growth %	-0.26	6.34	-18.14	22.91	12.47
Capital Expenditures, 1 Yr. Growth %	-21.35	12.5	3.81	98.17	44.14
Levered Free Cash Flow, 1 Yr. Growth %	-3.77	-39.2	189.34	-122.52	-23.82
Unlevered Free Cash Flow, 1 Yr. Growth %	-5.95	-38.33	178.27	-116.85	-26.08
Dividend Per Share, 1 Yr. Growth %	23.08	18.75	21.05	13.04	2.56
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.32	4.89	9.62	12.82	2.6
Gross Profit, 2 Yr. CAGR %	27.3	4.89	9.62	-7.41	1.18
EBITDA, 2 Yr. CAGR %	10.91	1.81	10	7.44	1.18
EBITA, 2 Yr. CAGR %	13.54	2.69	12.44	7.4	-0.93
EBIT, 2 Yr. CAGR %	25.71	7.34	16.68	9.47	-0.07
Earnings From Cont. Operations, 2 Yr. CAGR %	34.03	16.88	-4.69	-1.93	18.9
Net Income, 2 Yr. CAGR %	37.66	16.88	-63.93	-8.71	198.76
Normalized Net Income, 2 Yr. CAGR %	35.76	9.1	14.58	8.49	-2.4
Diluted EPS Before Extra, 2 Yr. CAGR %	33.33	16.9	-4.62	-0.33	21.38
Accounts Receivable, 2 Yr. CAGR %	29.61	-10.17	-9.92	17.66	19.62
Inventory, 2 Yr. CAGR %	1.65	4.45	12.26	12.96	18.66
Net Property, Plant and Equip., 2 Yr. CAGR %	8.11	9.19	10.4	11.55	21.02
Total Assets, 2 Yr. CAGR %	3.28	7.02	5.93	5.65	20.3
Tangible Book Value, 2 Yr. CAGR %	15.64	18.8	8.03	-7.34	-5.7
Common Equity, 2 Yr. CAGR %	7.41	12.63	3.58	-7.69	0.46
Cash From Operations, 2 Yr. CAGR %	10.59	2.99	-6.7	0.31	17.58
Capital Expenditures, 2 Yr. CAGR %	-17.36	-5.93	8.07	43.43	69
Levered Free Cash Flow, 2 Yr. CAGR %	32.98	-23.51	24.19	-17.79	-8.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	25.34	-23.84	23.02	-30.28	-12.54
Dividend Per Share, 2 Yr. CAGR %	15.47	20.89	19.9	16.98	7.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.76	9.72	5.5	9.08	7.45
Gross Profit, 3 Yr. CAGR %	22.51	22.19	5.5	-4.38	-6
EBITDA, 3 Yr. CAGR %	91.98	8.2	6.8	3.76	9.69
EBITA, 3 Yr. CAGR %	128.81	10.39	8.51	3.58	10.33
EBIT, 3 Yr. CAGR %	45.86	19.51	13.24	6.36	12.25
Earnings From Cont. Operations, 3 Yr. CAGR %	0.57	27.07	2.8	0.95	6.28
Net Income, 3 Yr. CAGR %	-26.8	29.35	-46.21	-1.63	0.56
Normalized Net Income, 3 Yr. CAGR %	32.32	23.73	14.99	3.81	11.31
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.46	26.51	2.97	2.04	7.81
Accounts Receivable, 3 Yr. CAGR %	3.89	13.84	-9.33	-3.25	21.07
Inventory, 3 Yr. CAGR %	4.17	8.44	3.66	16.35	12.87
Net Property, Plant and Equip., 3 Yr. CAGR %	10.29	10.81	7.68	13.14	15.32
Total Assets, 3 Yr. CAGR %	-1.15	7.56	3.28	9.2	11.65
Tangible Book Value, 3 Yr. CAGR %	15.99	18.83	9.49	2.52	-6.13
Common Equity, 3 Yr. CAGR %	6.24	10.99	4.72	0.33	-2.97
Cash From Operations, 3 Yr. CAGR %	28.23	9.15	-4.6	2.28	4.21
Capital Expenditures, 3 Yr. CAGR %	14.2	-8.41	-2.79	32.27	43.66
Levered Free Cash Flow, 3 Yr. CAGR %	8.88	2.44	14.07	-28.84	35.92
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.09	-1.05	12.49	-35.82	30.19
Dividend Per Share, 3 Yr. CAGR %	13.3	16.55	20.95	17.57	11.96
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.79	7.59	9.71	8.77	4.33
Gross Profit, 5 Yr. CAGR %	8.2	16.63	17.18	7.21	-3.71
EBITDA, 5 Yr. CAGR %	1.29	17.47	53.64	6.56	5.16
EBITA, 5 Yr. CAGR %	2.31	27.51	72.21	7.46	5.51
EBIT, 5 Yr. CAGR %	7.06	58.09	33.4	13.71	8.66
Earnings From Cont. Operations, 5 Yr. CAGR %	44.89	61.61	-1.57	13.07	8.96
Net Income, 5 Yr. CAGR %	30.18	48.34	-44.85	12.52	6.79
Normalized Net Income, 5 Yr. CAGR %	22.38	51.51	24.91	15.57	8.71
Diluted EPS Before Extra, 5 Yr. CAGR %	43.1	60.5	-2.14	13.56	9.97
Accounts Receivable, 5 Yr. CAGR %	-9.73	-13.57	-1.88	8.76	1.3
Inventory, 5 Yr. CAGR %	-5.09	0.41	7.33	10.23	9.42
Net Property, Plant and Equip., 5 Yr. CAGR %	2.01	7.64	10.34	11.1	12.83
Total Assets, 5 Yr. CAGR %	-7.22	-2.45	1.63	6.79	9.78
Tangible Book Value, 5 Yr. CAGR %	2.49	5.69	12.73	7.58	3.14
Common Equity, 5 Yr. CAGR %	-3.12	0.83	5.17	3.1	2.99
Cash From Operations, 5 Yr. CAGR %	3.03	20.11	12.92	5.53	3.72
Capital Expenditures, 5 Yr. CAGR %	22.14	20.11	11.71	9.59	21.28
Levered Free Cash Flow, 5 Yr. CAGR %	17.39	6.84	14.76	-8.62	5.19
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.94	-0.13	11.92	-16.12	2.45
Dividend Per Share, 5 Yr. CAGR %	29.86	13.7	15.9	16.72	15.45